Parathyroid hormone may be a promising therapy for bisphosphonate-related osteonecrosis of jaw bones

Int J Oral Maxillofac Surg. 2013 Jan;42(1):149-50. doi: 10.1016/j.ijom.2012.05.034. Epub 2012 Jul 2.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Bisphosphonate-Associated Osteonecrosis of the Jaw / pathology*
  • Bone Density Conservation Agents / adverse effects*
  • Diphosphonates / adverse effects*
  • Humans
  • Jaw Diseases / pathology*
  • Osteomyelitis / pathology*
  • Osteoradionecrosis / pathology*

Substances

  • Bone Density Conservation Agents
  • Diphosphonates